Gain Therapeutics, Inc.
GANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819411
No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Gain Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +3 vs. Q2 2025
- Shares held
- 4.34M
- +553.8K (+14.6%) vs. Q2 2025
- Total value
- $7.70M
- +$1.21M (+18.7%) vs. Q2 2025
- New holders
- 9
- 14 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 50 | $17.4M |
| Q1 2026 | 42 | $15.8M |
| Q4 2025 | 48 | $25.9M |
| Q3 2025 | 38 | $7.70M |
| Q2 2025 | 35 | $6.49M |
| Q1 2025 | 33 | $5.07M |
| Q4 2024 | 25 | $3.94M |
| Q3 2024 | 19 | $2.40M |
| Q2 2024 | 28 | $3.89M |
| Q1 2024 | 26 | $7.04M |
| Q4 2023 | 24 | $5.05M |
| Q3 2023 | 24 | $4.95M |
| Q2 2023 | 24 | $5.68M |
| Q1 2023 | 22 | $5.54M |
| Q4 2022 | 21 | $3.78M |
| Q3 2022 | 23 | $3.95M |
| Q2 2022 | 16 | $3.87M |
| Q1 2022 | 16 | $4.75M |
| Q4 2021 | 19 | $5.71M |
| Q3 2021 | 14 | $6.65M |
| Q2 2021 | 14 | $8.95M |
| Q1 2021 | 12 | $15.0M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Gain Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 2,064 | $3.65K | 0.00% | +1,119+118.4% | Added |
| Wells Fargo & Company | 2,650 | $4.69K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 3,250 | $5.75K | 0.00% | +750+30.0% | Added |
| Bank of America Corp | 3,907 | $6.92K | 0.00% | −257−6.2% | Reduced |
| MAI Capital Management | 4,410 | $7.81K | 0.00% | 00.0% | Unchanged |
| Creekmur Asset Management LLC | 4,440 | $7.86K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 10,600 | $18.8K | 0.00% | 00.0% | Unchanged |
| Armis Advisers, LLC | 10,750 | $19.8K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 11,574 | $20.5K | 0.00% | +11,574 | New |
| Kestra Advisory Services, LLC | 12,000 | $21.2K | 0.00% | +12,000 | New |
| Sandhill Capital Partners LLC | 15,400 | $27.3K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 16,775 | $29.7K | 0.00% | +10,374+162.1% | Added |
| Wealth Enhancement Advisory Services, LLC | 15,556 | $31.4K | 0.00% | +15,556 | New |
| HRT Financial LP | 19,717 | $34.0K | 0.00% | +19,717 | New |
| JPMorgan Chase & Co | 26,280 | $46.5K | 0.00% | +26,280 | New |
| Two Sigma Securities, LLC | 27,323 | $48.4K | 0.01% | +27,323 | New |
| Bridgeway Capital Management, LLC | 30,004 | $53.1K | 0.00% | 00.0% | Unchanged |
| Benedict Financial Advisors Inc | 35,000 | $62.0K | 0.01% | +12,500+55.6% | Added |
| Prelude Capital Management, LLC | 35,820 | $63.4K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 38,537 | $68.2K | 0.00% | +38,537 | New |
| Kovitz Investment Group Partners, LLC | 47,578 | $84.2K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 54,202 | $95.9K | 0.00% | +54,202 | New |
| Virtu Financial LLC | 54,008 | $96.0K | 0.01% | +30,207+126.9% | Added |
| Jane Street Group, LLC | 72,450 | $128.2K | 0.00% | +72,450 | New |
| Susquehanna International Group, LLP | 80,435 | $142.4K | 0.00% | +884+1.1% | Added |
| Northern Trust Corp | 88,399 | $156.5K | 0.00% | −11,771−11.8% | Reduced |
| State Street Corp | 91,137 | $161.3K | 0.00% | +20,000+28.1% | Added |
| BlackRock, Inc. | 116,184 | $205.6K | 0.00% | +3,677+3.3% | Added |
| Renaissance Technologies LLC | 126,100 | $223.2K | 0.00% | +32,100+34.1% | Added |
| UBS Group AG | 140,677 | $249.0K | 0.00% | +108,042+331.1% | Added |
| Morgan Stanley | 155,675 | $275.5K | 0.00% | +79,163+103.5% | Added |
| Marshall Wace, LLP | 175,107 | $309.9K | 0.00% | −101,326−36.7% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 318,645 | $564.0K | 0.00% | +139,145+77.5% | Added |
| Geode Capital Management, LLC | 344,146 | $609.2K | 0.00% | +53,684+18.5% | Added |
| Citadel Advisors LLC | 373,558 | $661.2K | 0.00% | +211,742+130.9% | Added |
| Vanguard Group Inc | 534,352 | $945.8K | 0.00% | 00.0% | Unchanged |
| DME Capital Management, LPSuperinvestorGreenlight Capital | 566,130 | $1.00M | 0.04% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 676,822 | $1.21M | 0.00% | −660.0% | Reduced |
| Dauntless Investment Group, LLC | 0 | $0 | 0.00% | −46,000−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −12,756−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5,657−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −1,194−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −245,896−100.0% | Sold out |